Amphetamine/dextroamphetamine Sales Data
| Rank 66 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows amphetamine/dextroamphetamine U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 66 ( 1) |
$240,482 | 2.78% | 739 | 5.27% |
| Q3 2013 | 67 ( 14) |
$233,987 | -9.43% | 702 | -5.77% |
| Q2 2013 | 53 (2) |
$258,342 | -2.74% | 745 | -2.49% |
| Q1 2013 | 55 (6) |
$265,628 | -0.69% | 764 | -0.13% |
| Q4 2012 | 49 (1) |
$267,476 | -1.85% | 765 | 11.84% |
| Q3 2012 | 50 (1) |
$272,504 | -0.97% | 684 | 3.95% |
| Q2 2012 | 51 (4) |
$275,171 | -0.10% | 658 | 0.61% |
| Q1 2012 | 55 (1) |
$275,447 | -1.02% | 654 | 1.71% |
| Q4 2011 | 54 (3) |
$278,276 | 9.03% | 643 | 8.98% |
| Q3 2011 | 57 (9) |
$255,231 | 3.47% | 590 | 2.25% |
| Q2 2011 | 66 (9) |
$246,683 | 7.09% | 577 | 7.25% |
| Q1 2011 | 75 | $230,361 | n/a | 538 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
